-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5

Benzinga·10/23/2026 12:56:28
Listen to the news
Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.